摘要
目的分析Hs—TSH维持水平与ATD治疗Graves病甲亢预后的关系。方法对ATD治疗136例Graves病进行了回颐性分析，观察停药1年、2年及3年甲亢的复发率，分析Hs-TSH维持水平与复发率的关系。结果ATD治疗停药后1年，甲亢的复发率分别是：TSH减低组15．3％，TSH正常组3．5％，TSH增高组1．3％，相比有统计学意义。停药后3年，复发率TSH正常组与TSH增高组相当，且明显低于TSH减低组（P〈0．05）。结论血清Hs—TSH值可以作为判断ATD治疗预后的一个良好指标。
Objective To observe the relationship of the Hs-TSH and prognosis of GD with ATD. Methods 136 GD patients with ATD were retrospectively analyzed. The rate of recurrence were compared after treatment 1 year, 2 year and 3 year. To observe the relationship of the Hs-TSH and recurrence of GD with ATD. Results The rate of reeurrenee is 15.3%, 3.5% and 1.3% after treatment 1 year in TSH deereasing group, TSH normal group and TSH inereasing group, Compared the there groups were statistically significant （ P〈 0.01 ）. The rate of recurrence is same in TSH normal group and TSH increasing group after treatment 3 year, whiteh is lower than the TSH decreasing group （ P〈 0.05 ）. Conclusions Hs-TSH can be regarded an index to judge the prognosis treated with ATD.
出处
《国际医药卫生导报》
2011年第3期281-283,共3页
International Medicine and Health Guidance News
